Multiple Myeloma Flashcards

(44 cards)

1
Q

What is multiple myeloma

A

DisseminatedDisease due to malignant transformation of differentiated B cells
Usually secrete monoclonal immunoglobulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Crab features of multiple myeloma

A

C- hypercalcemia
R- renal impairment
A- anemia
B- bone disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is monoclonal gammopathy in multiple myeloma

A

Peak in only one type of antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Percentage of clonal plasma cells on bone marrow examination in multiple myeLoma

A

60% or more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the defining events in multiple myeloma

A

60% or more Clonal plasma cell on bone marrow examination

Involved or uninvolved free light chain ratio of 100 or greater in serum
At least 100 mg/L of involved free light chain

More than one focal lesion on MRI at least 5 mm or greater

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Second most present hematological disease

A

Multiple myeLoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Percentage of multiple myeloma in all cancer

A

One percent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is plasmacytoma

A

Collection of plasma cells anywhere in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Percentage of multiple myeLoma in hematological malignancies

A

10 to 13 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

People at risk of multiple myeLoma

A

Old people around 70 years

2/3 more than 65yo when diagnosed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is monoclonal gammopathy of undetermined significance ( MGUS)

A

Prolonged asymptomatic phase that may last for years where there is monoclonal gammopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When do you say that there is a symptomatic or smoldering myeloma

A

Same laboratory as multiple myeLoma (calcium, renal function , high plasma cells in bone marrow ..)

no organ or tissue damage with no clinical features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Percentage of chance that an asymptomatic myeloma becomes multiple myeloma

A

10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pathogenesis of multiple myeLoma

A

Class switching, somatic hyper mutation and  Immunoglobulin gene recombination in plasma cell which becomes myeloma cell

Overexpression of adhesion molecule of adhesion molecule on plasma cell clone
Overexpression of Extracellular matrix proteins, matrix stromal cells, intercellular adhesion molecules, vascular cell adhesion molecules

It direction leading to secretion of interleukins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the phenotype of malignant plasma cell

A

High CD38
High CD138
Low cD45

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why is there hyperviscosity syndrome in multiple myeloma

A

increased protein content and large molecular size, abnormal polymerization, and abnormal shape of immunoglobulin molecules.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Presentation of hyperviscosity syndrome

A

Confusion

disorientation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What determines the severity of Hyperviscosity syndrome inmultiple myeLoma

A

If it’s a IgA ( dimer) or IgM( pentamer )because they have the biggest size

19
Q

Why is there a reduced immunity in multiple myeloma

A

Reduce the production of normal immunoglobulin

20
Q

What disease is a hallmark of multiple myeloma

21
Q

Why is there bone disease such as osteolysis in multiple myeLoma

A

Osteoclast activity increase -> secretion of osteoclast activating factors (TNF-alpha, IL6, IL1, hepatocytes growth factors, parathyroid hormone, RANKL, VEGF ,MIP-1a)
memorize RANK-L and MIP-1a

Decreased osteoprotegerin OPG

22
Q

Bone disease progression in multiple my Loma

A

Osteoporosis -> Lytic lesions -> Pathological fractures

23
Q

What are the cytogenetic changes in multiple myeloma

A

Multiple structural chromosome changes

13q loss
Hyperdiploidy
Hypodiploidy
Chrom 8, 13,14, loss 
Del(17p)
24
Q

Presentation of multiple myeloma

A

Skeletal (bone pain, fractures , paraplegia ,quadriplegia)
marrow infiltration (Marrow failure anemia, neutropenia, thrombocytopenia)
infection
renal failure
Symptoms of hyper viscosity
Thrombosis
Bleeding

25
Why is there infection in multiple myeloma
Due to decreased normal immunoglobulin
26
Why is there a renal failure in multiple my Loma
Obstruction of distal renal tubules by proteinaceous casts -> atrophy, interstitial fibrosis Hypercalcemia infection uric acid amyloidosis
27
What are some prothrombotic abnormalities in multiple my Loma
High factor VIII Acquired activated protein C resistance HYPOfibrinolysis Immune modulatorY DRUGS like thalidomide and lenalidomide used to treat MM
28
Why is there a bleeding in multiple myeloma
Non-functional platelets interference with fibrin polymerization thrombocytopenia from bone suppression suppression
29
Diagnosis of MM
``` Full blood counts - thin film rouleaux, leucoerythroblastosis ESR increased Bone marrow > 10% plasma cells Paraprotein in serum Bence jones protein in urine Reduced normal IgG and albumin Serum B2 microglobulin increased C reactive protein increased Skeletal survey ```
30
What are the diagnostic criteria for MM
Paraprotein in serum and or urine Bone marrow clonal plasma cell/ plasmacytoma Tissue impairment or myeloma related organs with end organ damage - crab manifestation
31
Poor prognostic factors in MM
``` More than 65 years old Poor performance status HB < 8.5 G/DL Hypercalcemia Advanced lytic bone lesions Abnormal renal function Serum albumin < 30g/l B2 microglobulin > 6mg High C reactive protein ```
32
Staging of MM
``` Stage l • Beta-2 microglobulin < 3.5g/dL and albumin ≥3.5g/dL Stage Il • Beta-2 microglobulin <3.5g/dL Albumin <3.5 g/dL OR • Beta-2 microglobulin level ≥3.5 to <5.5 g/dL Stage Ill • Beta-2 microglobulin ≥5.5 g/dL ```
33
Supportive treatment of MM
``` Transfusion - anemia Analgesics - pain Allopurinol - Uric acid Hydration and steroids - serum calcium Biphosphonates , radiotherapy - lytic lesions Orthopedic surgery - fractures Hydration, steroids, treat infection - renal failure Antibiotics - infection Radiotherapy - pain , fractures ```
34
Drugs given in primary induction for therapy in transplant candidates
``` Bortezomib dexamethasone doxorubicin Thalidomide Lenalidomide ``` VAD - first line
35
Treatment used for relapse or refractory disease
``` Different agent than one used in first line Bortezomid Cyclophosphamide Dexamethasone Car fil zombi Thalidomide Lenalidomide Pomalidomide ```
36
Median survival from diagnosis in MM
4 to 5 years
37
What’s presentation shows the worst prognosis
Renal failure
38
Features of plasma cell
Eccentric nucleus Basophilic cytoplasm Perinuclear halo
39
Differential diagnosis of MM
Monoclonal gammopathy of undermine significance Smoldering multiple myeloma Plasmacytoma Amyloidosis Waldenstrom macroglobulinemia Heavy chain disease
40
What is Amyloidosis
Disorder of protein folding which were soluble but now are deposited as beta pleated sheet
41
Complication of Amyloidosis
Dysfunction and organ failure
42
Types of Amyloidosis
AL AA familial amyloid
43
Classical features of amyloidosis
Malabsorption Nephrotic syndrome Cardiomyopathy Macroglossia Carpal tunnel syndrome Peripheral neuropathy Purpura
44
What is waldenstrom macroglobulinaemia
Presence of paraprotein IgM leading to organ infiltration and hyper viscosity